Artiva Biotherapeutics, Inc. (ARTV) KPIs and segments
ARTVNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.86−0.10 (-2.53%)
Close on Nov 17, 2026Market cap $188.72MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Artiva Biotherapeutics's business
Coming soon
This tab will track the numbers specific to Artiva Biotherapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?